Discover the range of academic oncology titles at Springer Nature here.
Collections open for submissions: Call for papers
This series, guest edited by Prof. Hua Zhang (Guangdong Medical University, China), will focus on noncoding RNAs to serve as biomarkers for diagnosis, prognosis, as well as therapy in both malignant and non-malignant disorders.
For this collection, guest edited by Dr. Jeon-Hor Chen (University of California, Irvine), we cordially invite manuscripts from different disciplines. High quality manuscripts related to disease diagnosis, prediction of treatment response, and assessment of disease risk and outcome are encouraged. Manuscripts outside of these topics which are within the scope of translational research are also welcome.
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Springer Nature Oncology Portfolio
Chung-Tsen Hsueh, Loma Linda University
Delong Liu, New York Medical College
Aims and scope
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. Read more.
Announcing the launch of In Review
Biomarker Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Annual Journal Metrics
13 days to first decision for all manuscripts
30 days to first decision for reviewed manuscripts only
72 days from submission to acceptance
15 days from acceptance to publication
6.148 - 2-year Impact Factor
5.722 - 5-year Impact Factor
1.452 - Source Normalized Impact per Paper (SNIP)
1.633 - SCImago Journal Rank (SJR)
501,310 Downloads (2021)
73 Altmetric mentions
On the blog
03 February 2022
16 April 2021